Mesoporous carbon‑manganese nanocomposite for multiple imaging guided oxygen-elevated synergetic therapy

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Photodynamic therapy (PDT) faces challenges including photosensitizer hydrophobicity, low selectivity, and tumor hypoxia.
• Existing PDT approaches often suffer from unintended phototoxicity and limited tumor penetration.

Purpose of the Study:

• To develop a multifunctional mesoporous carbon-manganese nanocomposite (MC-MnO2) for enhanced cancer therapy and diagnosis.
• To address the limitations of conventional PDT by improving photosensitizer loading, reducing off-target effects, and mitigating tumor hypoxia.

Main Methods:

• Fabrication of a mesoporous carbon-manganese nanocomposite (MC-MnO2) for high-capacity loading of Chlorin e6 (Ce6).
• Decoration of the nanocomposite with PEG and iRGD (iPMC-MnO2) to enhance biocompatibility, tumor targeting, and penetration.
• Integration of PDT with photothermal therapy (PTT) and utilization of Mn2+ for MRI contrast and O2 generation for hypoxia relief.

Main Results:

• The developed MC-MnO2 effectively loaded Ce6, preventing premature activation and reducing phototoxicity.
• The nanocomposite demonstrated hypoxia relief in tumor tissues by reacting with overexpressed H2O2, with Mn2+ acting as an MRI contrast agent.
• The nanoparticle exhibited potent photothermal effects and facilitated enhanced PDT, enabling multimodal imaging and therapy.

Conclusions:

• The multifunctional iPMC-MnO2 nanoplatform offers a promising solution for integrated cancer diagnosis and therapy.
• This approach successfully combines PDT, PTT, and MRI, addressing key limitations of individual treatments for improved therapeutic outcomes.
• The developed nanoplatform represents a significant advancement towards an "one nanoparticle fits all" strategy for cancer treatment.